Остеопороз у больных бронхиальной астмой

1. Насонов Е.Л., Скрипников И.А., Насонова В.А. Проблема остеопороза в ревматологии.- М.: Стин, 1997.

2. Чучалин А.Г., Берова М.М. Функциональное состояние кальцийрегулирующей системы у больных бронхиальной астмой / / Клин мед.- 1989.- Т.67, № 8.- С.56-59.

3. Adachi J.D., Bensen W.G., Bianchi F. et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year follow-up / / J. Rheumatol.- 1996.- Vol.23, № 6.- P.995-1000.

4. Balsan S., Steru D., Bourdeau A. et al. Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth / / Calcif. Tissue int.- 1987.- Vol.40, № 6.- P.303-309.

5. Barnes N.C. Safety of high-dose inhaled corticosteroids / / Respir. Med.- 1993.- Vol.87.- Suppl.A.- P.27-31.

6. Binz K., Schmid C., Bouillon R. et al. Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density and mineral metabolism in rats / / Eur. J. Endocrinol.- 1994.- Vol. 130.- P.387-393.

7. Bootsma G.P., Deckhuijzen P.N.R., Festen J., van Herwaarden C.L.A. Effects of inhaled corticosteroids in asthma / / Allergy.- 1997.- Vol.52.- Suppl.39.- P .l-34.

8. Boutsen Y., Jamart J., Esselinckx W. et al. Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial / / Calcif. Tissue int.- 1997.- Vol.61, № 4.- P.266-271.

9. Brandli D.W., Golde G., Greenwald M ., Silverm an S.L. Glucocorticoid-induced osteoporosis: a cross-sectional study / / Steroids.- 1991.- Vol.56, № 10.- P.518-523.

10. Delany A.M., Dong Y., Canalis E. Mechanisms of glucocorticoid action in bone cells / / J. Cell Biochem.- 1994.- Vol.56, № 3.- P.295-302.

11. Delany A.M., Gabbitas B.Y., Canalis E. Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms / / Ibid.- 1995.- Vol.57, № 3.- P.488-494.

12. Delmas P., Seeman E., Liunghall S. et al. Alendronate in postmenopausal and glucocorticoid-induced osteoporosis / / Osteoporos. intern.- 1998.- Vol.8.- Suppl.3.- P.133.

13. Diamond T., M cGuigan L., Barbagallo S., Bryant C. Cyclic etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women / / Amer. J. Med.- 1995.- Vol.98, № 5.- P.459-463.

14. Eastell R., Reid D M ., Compston J. et al. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update / / J. intern. Med.- 1998.- Vol.244.- P.271-292.

15. Fabbri L.M., Piattela M., Caramori G., LiacciaA. Oral vs inhaled asthma therapy. Proc, cons and combinations / / Drugs.- 1996.- Vol.52.- Suppl.6.- P.20-28.

16. Gennari C. Differential effect of glucocorticoids on calcium absorbtion and bone mass / / Brit. J. Rheumatol.- 1993.- Vol.32.- Suppl.2.- P.l1-14.

17. Gronowicz G.A., M cCarthy M .B. Glucocorticoid inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta 1 -integrin levels / / Endocrinology.- 1995.- Vol. 136, № 2.- P.598-608.

18. Guaydier-Souquieres G., Kotzki P.O., Sabatier J.P. et al. In corticosteroid-treaterd respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study / / Osteoporos. intern.- 1996.- Vol.6, № 2.- P.171-177.

19. Gulko P.S., M ulloy A.L. Glucocorticoid-induced ostoporosis: pathogenesis, prevention and treatment / / Clin. exp. Rheumatol.- 1996.- Vol.14, No 2.- P.199-206.

20. Hanania N.A., Chapman K.R., Kesten S. Adverse effects of inhaled corticosteroids / / Amer. J. Med.- 1995.- Vol.98.- P. 196-204.

21. Herrala Puolijoki H., Imprivaara O. et al. Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate / / Bone.- 1994.- Vol. 15, № 6.- P.621-623.

22. Herrala J., Puolijoki H., Liippo K. et al. Clodronate is effective in preventing corticosteroid induced bone loss among asthmatic patients / / Ibid.- 1998.- Vol.22, № 5.- P.577-582.

23. Lacronique J. Primum non nocere: inhaled corticoids / / Rev. Pneumol. Clin.- 1996.- Vol.52, № 2.- P.137-143.

24. Laroche M., Porteau L., Caron P. et al. Osteoporotic vertebral fractures in man under high-dose inhaled glucocorticoid therapy. A case-report with a review of the literature / / Rev. Rhum. Engl. Ed.- 1997.- Vol.64, № 4.- P.267-270.

25. Ledford D., Apter A., Brenner A.M . et al. Osteoporosis in the corticosteroid-treated patient with asthma / / J. Allergy clin. Immunol.- 1998.- Vol.102, № 3.- P.353-362.

26. Luengo M., Picado C., Del Rio L. et al. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma / / Amer. Rev. respir. Dis.- Vol. 142.- P. 104-107.

27. Luengo M., Picado C., Del Rio L. et al. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study / / Thorax.- 1991.- Vol.46, № 11.- P.803-806.

28. Luengo M., Picado C., Piera C. et al. Intestinal calcium absorbtion and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment / / Eur. Respir. J.- 1991.- Vol.4, № 4.- P.441-444.

29. Luengo M., Pons F.t M artinez de Osaba M.J., Picado C. Prevention of futher bone loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study / / Thorax.- 1994.- Vol.49, N2 11.- P.1099-1102.

30. Lukert B.P., Raisz L.G. Glucocorticoid-induced osteoporosis: pathogenesis and management / / Ann. intern. Med.- 1990.- Vol. 112, N2 5.- P.352-364.

31. Lukert B.P., Johnson B.E., Robinson R.G. Estrogen and progesterone replacement therapy reduced glucocorticoid-induced bone loss / / J. Bone Miner. Res.- 1992.- Vol.7.- P. 1063-1069.

32. M acAdams M.R., White R.H., Chipps B.E. Reduction of serum testosterone levels during chronic glucocorticoid therapy / / Ann. intern. Med.- 1986.- Vol.104.- P.648-651.

33. M arkham A., Bryson H.M. Deflazacort. A review of its pharmacological properties and therapeutic efficacy / / Drugs.- 1995.- Vol.50, № 2.- P.317-333.

34. McLeod J.F. Osteoporosis, cytokines, and glucocorticoids / / Allergy Proc.- 1993.- Vol. 14, N2 5.- P.363-364.

35. Morrison N.A., Shine J., Verkest V. et at. 1,25-Dihydroxyvitamin D responsive element and glucocorticoid repression in the osteocalcin gene / / Science.- 1989.- Vol.246.- P. 1158-1161.

36. M yers J.R., Sherman C.B. Should supplemental estrogens be used as steroid-sparing agents in asthmatic women? / / Chest.- 1994.- Vol.106, No 1.- P.318-319.

37. Peretz A., Praet J.R., Bosson D. et al. Serum osteocalcin in the assesment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment / / J. Rheumatol.- 1989.- Vol. 16, No 3.- P.363-367.

38. Picado C., Luengo M. Corticosteroid-induced bone-loss. Prevention and management / / Drug Saf.- 1996.- Vol.15, N2 5.- P.347-359.

39. Reid I.R. Glucocorticoid osteoporosis - mechanisms ana management / / Eur. J. Endocrinol.- 1997.- Vol. 137, № 3.- P.209- 217.

40. Reid I.R., Ibbertson H.K. Evidence for decreased tubular reabsorption of calcium in glucocoricoid-treated asthmatic / / Horm. Res.- 1987.- Vol.27, N2 4.- P.200-204.

41. Reid I.R., W attie D.J., Evans M.C., Stapleton J.P. Testosterone therapy in glucocorticoid-treated men / / Arch, intern. Med.- 1996.- Vol. 156, № 11.- P. 1173-1177.

42. Sambrook P., Birmingham J., Kelly P. et al. Prevention of corticosteroid osteoporosis / / New Engl. J. Med.- 1993.- Vol.328, No 24.- P.1747-1752.

43. Schatz M., Dudl J., Zeiger R.S. et al. Osteoporosis in corticosteroid-treated asthmatic patients: clinical correlates / / Allergy Proc.- 1993.- Vol.14, No 5.- P.341-345.

44. Scutt A., Bertram P., Bräutigam M. The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchimal cells to the osteoblastic lineage: positive and negative effects / / Calcif. Tissue int.- 1996.- Vol.59, № 3.- P. 154-162.

45. Sebaldt R.J., Adachi S.D., Bensen W.G. et al. Intermittent cyclic therapy with etidronate prevents cortocosteroid-induced bone loss: two years of follow-up / / Scand. J. Rheumatol.- 1996.- Suppl.103.- P.91-93.

46. Smith B.J., Buxton J.R., Dickeson J., Heller R.F. Does beclomethasone dipropionate supress dehydroepiandrosterone sulphate in postmenopausal women? / / Aust. N. Z. J. Med.- 1994.- Vol.24, No 4.- P.396-401.

47. Toogood J.H., Jennings B., Hodsman A.B. et al. Effects of dose and dosing schedule of inhaled budesonide on bone turnover / / J. Allergy clin. Immunol.- 1991.- Vol.88, № 4.- P.572-580.

48. Walsh L.J., Tattersfield A.E. Bone disease in asthma / / Brit. J. hosp. Med.- 1997.- Vol.57, № 8.- P.390-393.

49. Ward M.J. Inhaled corticosteroids - effect on bone? / / Respir. Med.- 1993.- Vol.87.- Suppl.A.- P.33-35.

50. Wisniewski A.F., Lewis S., Maslanka W.B. et al. A cross-sectional study of the effects of inhaled steroids on bone density and bone metabolism in patients with asthma / / Amer. J. Respir. Crit. Care Med.- 1995.- Vol. 151.- P.A 374.

51. Worth H., Stammen D., Keck E. Therapy of steroid-induced loss in adult asthmatics with calcium, vitamin D, and a diphosphonate / / Ibid.- 1994.- Vol. 150, N2 2.- P.394-397.

52. Yamada H. Long-term effect of 1 alpha-hydroxyvitamin D, calcium and thiazide administration on glucocorticoid-induced osteoporosis / / Nippon Naibunpi Gakkai Zasshi.- 1989.- Vol.65, № 6.- P.603-614.